Trial intelligence / Profile preview

Pantoprazole and Prolonged HDMTX Infusion in Osteosarcoma

NCT01848457Phase 2Completed

Sponsor
Children's Hospital of Philadelphia
Start
Apr 2013
Primary completion
Jan 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of pantoprazole in nephrotoxicity, ototoxicity, sponsored by Children's Hospital of Philadelphia. Started Apr 2013; status: completed.

02

Drugs

pantoprazole
03

Conditions

nephrotoxicityototoxicity

Beyond the preview

Go deeper on NCT01848457.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01848457.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call